AzurRx Begins Phase 2b Trial Testing MS1819 for Pancreatic Insufficiency in CF Patients
AzurRx BioPharma has launched a Phase 2b clinical trial investigating its MS1819 as a potential treatment for exocrine pancreatic...
AzurRx BioPharma Will Conduct Phase 2b Trial of MS1819 at TDN Clinical Sites
AzurRx BioPharma has been authorized to conduct its Phase 2b OPTION 2 clinical trial evaluating MS1819, its investigative therapy for...
Acebilustat Seen to Prevent Pulmonary Exacerbations in CF Patients in Phase 2b Trial
Topline data from a Phase 2b trial showed that the investigative therapy acebilustat taken once daily can reduce the number and frequency...
Corbus Pharma (CRBP) Reports Agreement with FDA on Phase 2b Cystic Fibrosis Study Design with Pulmon
Multi-national Phase 2b is designed to provide clear evidence of clinical benefit of lenabasum (formerly known as anabasum) in patients...